baber/WOPTO huggingface dataset:
Patent CA-2362617-A1 (CA)
Inventor: MELOUL RAPHAEL F
IPC: A61M25/10
Filed: 1995-10-23
Abstract: This invention is an apparatus and method for delivering a treating element (22), such as a radiation source, through a catheter (60) to a desired site in a vascular system of a patient, such as a coronary artery, for inhibiting the formation of scar tissue such as may occur in restenosis following balloon angioplasty. The apparatus includes an elongate flexible catheter tube (20) having proximal and distal portions, with a lumen (202) extending therebetween, and a diameter sufficiently small for insertion into the patient's vascular system. One or more treating elements (22), such as a capsule or pellet containing radioactive material, is positionable within the lumen and movable between the proximal and distal end portions under the force of a liquid flowing through the lumen. The treating element that is usable in such a system comprises an elongated hollow cylinder closed on each end and a radiation-emitting substance encapsulated by the cylinder.
Patent CA-2363141-A1 (CA)
Title: Microemulsions with adsorbed macromolecules and microparticles
Inventor: KAZZAZ JINA
IPC: A61K9/00
Filed: 2000-02-09
Abstract: Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed.  The microparticles comprise a polymer, such as a poly(.alpha.-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a poly-orthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided. Methods of stimulating an immune response, methods of immunizing a host animal against a viral, bacterial, or parasitic infection, and methods of increasing a Th1 immune response in a host animal by administering to the animal an immunogenic composition of the microparticles, and/or microemulsions of the invention, are also provided.
Patent CA-2366671-A1 (CA)
Title: Procedes et reactifs servant a determiner la specificite de substrats enzymatiques et utilisations correspondantes
Inventor: BACHOVCHIN WILLIAM
IPC: C12Q1/42
Filed: 2000-04-10
Abstract: L'invention concerne un procédé permettant de déterminer un motif préféré de séquence d'acides aminés pour un site actif d'une enzyme et ses sous-sites de spécificité associés. Selon le procédé de l'invention, on met en contact une enzyme avec une banque de peptides dégénérés orientés, certains peptides de la banque étant des substrats pour l'enzyme qui s'y lie, puis on sépare les complexes peptide/enzyme liés et non liés. Les peptides liés sont libérés de l'enzyme puis séquencés. On détermine un motif préféré de séquence d'acides aminés pour le site actif et ses sous-sites de spécificité associés en fonction de l'abondance relative des différents résidus d'acides aminés à chaque position dégénérée. L'invention concerne également des peptides, des analogues peptidiques et d'autres petites molécules convenant pour de nombreuses utilisations et pouvant être dérivés de l'invention.
Patent CA-2366876-A1 (CA)
Title: Ensemble de cylindres de compression
Inventor: DALLAND KNUT O
IPC: F15B15/14
Filed: 1999-03-02
Abstract: La présente invention concerne un ensemble (10') de cylindres de compression d'un milieu (11', 12') utilisés particulièrement lorsqu'on a besoin d'une course de longueur relativement grande. Au moins un premier (11') et au moins un second cylindre (12') sont disposés à côté l'un de l'autre, les axes longitudinaux (11a, 12a) étant parallèles entre eux. Les parties (13', 14) des cylindres sont reliées par paires les unes aux autres. Les tiges de piston (17', 18') des premiers et seconds cylindres sont orientés par paire selon des sens axiaux opposés d'une paire à l'autre.
Patent CA-2367983-A1 (CA)
Title: Low stress die attachment
Inventor: STALNAKER W MARC
IPC: G01V1/40
Filed: 2000-03-15
Abstract: A system for resiliently attaching a mass to a package. The system includes a mass, a housing, resilient couplings for resiliently attaching the mass to the housing, bumpers for slidingly supporting the mass, and electrical connections for electrically coupling the mass to the housing.
Patent CA-2373302-A1 (CA)
Inventor: HORWITZ DAVID L
IPC: A61K35/12
Filed: 2000-05-12
Abstract: Novel products comprising conditioned cell culture medium compositions and methods of use are described. The conditioned cell medium compositions of the invention may be comprised of any known defined or undefined medium and may be conditioned using any eukaryotic cell type. The medium may be conditioned by stromal cells, parenchymal cells, mesenchymal stem cells, liver reserve cells, neural stem cells, pancreatic stem cells and/or embryonic stem cells. Additionally, the cells may be genetically modified. A three-dimensional tissue construct is preferred. Once the cell medium of the invention is conditioned, it may be used in any state. Physical embodiments of the conditioned medium include, but are not limited to, liquid or solid, frozen, lyophilized or dried into a powder. Additionally, the medium is formulated with a pharmaceutically acceptable carrier as a vehicle for internal administration, applied directly to a food item or product, formulated with a salve or ointment for topical applications, or, for example, made into or added to surgical glue to accelerate healing of sutures following invasive procedures. Also, the medium may be further processed to concentrate or reduce one or more factors or components contained within the medium.
Patent CA-2373449-A1 (CA)
Inventor: MCHUGH DONALD
IPC: B24B3/00
Filed: 1999-05-10
Abstract: A skate blade sharpening machine includes an adjustable full-width dressing wheel (75) rotated by a separate electric motor (77) against the grinding wheel (13) of the skate sharpening machine.
Patent CA-2374238-A1 (CA)
Inventor: BALL SARAH CAROLINE
IPC: H01M8/10
Filed: 2000-06-14
Abstract: An electrically conducting gas diffusion substrate, capable of removing oxidisable impurities from an impure gas stream, which comprises an electrically conducting porous structure and a first catalytic component, wherein the first catalytic component comprises a first catalyst supported o n an electrically non-conducting support is disclosed. In addition, an electrode, a membrane electrode assembly and a fuel cell each comprising sai d electrically conducting gas diffusion substrate is disclosed.
Patent CA-2374413-A1 (CA)
Inventor: BAUGHN MARIAH R
IPC: C12N15/09
Filed: 2000-05-19
Abstract: L'invention concerne des protéines d'oxydoréductase humaines et des polynucléotides identifiant et codant pour ces protéines d'oxydoréductase humaines. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne en outre des méthodes permettant de diagnostiquer, de traiter ou de prévenir des troubles associés à l'expression des protéines d'oxydoréductase humaines.
Patent CA-2376867-A1 (CA)
Title: Procede et appareil de fabrication de produits et de mise en place d'etiquettes dans un moule
Inventor: HOOGLAND HENDRIK ANTONIUS
IPC: B29C45/26
Filed: 2000-08-21
Abstract: Procédé de fabrication d'étiquettes (2) destinées à être placées dans un moule, en particulier dans un moule pour injection, qui consiste à placer une bande de film (4), au niveau d'au moins une partie d'une première face, sur un support (6). Ensuite, un élément de retenue (14) est appliqué ou plus précisément légèrement pressé contre la seconde face, située à l'opposé du support (6), de la partie du film (4) soutenue par le support (6). La partie du film (4) enfermée entre le support (6) et l'élément de retenue (14) est séparée du film par coupure. La partie coupée du film, qui devient une étiquette (2), est maintenue par l'élément de retenue (14) et prélevée du support (6) à l'aide dudit élément.
Patent CA-2378339-A1 (CA)
Inventor: SANSOUCY MICHAEL R
IPC: A61M5/158
Filed: 2000-07-26
Abstract: A self-occluding catheter includes a body portion for connection to extracorporeal equipment. An elongated tubular extension is provided for insertion into a body cavity. The body portion includes a resiliently biased spool supported therein which is slidable between an open and a closed position for alternately permitting and stopping the flow of blood through the catheter during a given medical procedure. The biasing device for resilient biasing the spool preferably comprises one or more magnets fixed within the body portion which generate a magnetic force for urging the magnetically polarized spool to its closed position.
Patent CA-2380501-A1 (CA)
Inventor: THONNARD JOELLE
IPC: C07K14/21
Filed: 2000-07-27
Abstract: The invention provides BASB125 polypeptides and polynucleotides encoding BASB125 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
Patent CA-2380580-A1 (CA)
Inventor: ASHMAN ARTHUR
IPC: A61C8/00
Filed: 2000-08-18
Abstract: The present invention provides a kit system (12) comprising a plurality of disposable kits (10), each kit being adapted for post-extraction dental implantation on a particular dental area. Each kit (10) includes a dental implant (44) of specified dimensions for a particular dental area of the mouth, a transfer coping (46) attachable to the dental implant for creating an impression for making a model to produce a prosthetic tooth, bone graft material (66) for filling the void area around a portion of the implant afte r implantation, burrs (51) and bone expanders (53), and a portable housing (32 ) for storing the dental implant (44), the transfer coping (46), the bone graf t material (66), wound dressing (50), burrs (51) and bone expanders (53). Each  disposable kit includes indicia (42) which uniquely identifies it with the particular dental area of use. The kit system (12) may include a non- disposable instrument kit (14) including a plurality of reusable and sterilizable tools such as insertion instruments (58), a scissor (60), and a  suture holder (62), etc., for implementing post-extraction dental implantation, and a housing (50) for storing the instruments. The invention further provides a method of using the kits.
Patent CA-2381536-A1 (CA)
Inventor: MOLLER JOHN
IPC: H04L12/24
Filed: 2002-04-12
Abstract: A network administration system for an ad-hoc or 'sporatic' network where a ll logs are received and sent through a MILog agent at each network device. The  MILog agents route and filter logs accordingly to instructions received via Mobile  Interactive Logs (MILogs), and further provide other services such as creating MILogs. A  user is able to create and dispatch a MILog at any time to any MILog-compliant component from a  MILog agent authorized to create MILogs.
Patent CA-2381627-A1 (CA)
Title: Solid lubricant and composition
Inventor: MITROVICH MICHAEL J
IPC: C12Q1/68
Filed: 2002-04-11
Abstract: A solid lubricant and composition useful for lubricating the flanges of locomotive wheels, railcar wheels, rail track and in applications where it is desirable to reduce friction when metal contacts metal. The solid lubricant having from about twenty-five percent to about seventy percent by volume of a polymeric carrier, about five to seventy-five percent by volume of organic and inorganic extreme pressure additives, about zero to twenty percent by volume synthetic extreme pressure anti-wear liquid oil, and about zero to one percent by volume optical brightener.
Patent CA-2382010-A1 (CA)
Title: Dual compartment mixing and dispensing device
Inventor: LIFSHEY ARTHUR L
IPC: A61J1/10
Filed: 2000-09-08
Abstract: The present invention is directed to a dual compartment, mixing and dispensing device (10) suitable for the containment of two separate pharmaceutical components that mixable, upon breaking of a seal (18) that separates the compartments (11, 12), to provide an instantly mixed dose of medication. The medication can be administered to a patient through an aperture (15) located at one end of the device. The device is characterized as two compartments connected by a flexible, sealed orifice (18), wherein the two components are separated. Flexing of the device at the orifice breaks the seal (18a) and allows mixing of the components to prepare the dose. Thereafter, an end-portion of the device can be opened for oral administration of the dose.
Patent CA-2393441-A1 (CA)
Title: Perfectionnements apportes a la filtration sur membranes
Inventor: LANGLAIS CHRYSTELLE
IPC: C02F1/52
Filed: 2000-10-26
Abstract: Perfectionnements apportés à la filtration sur membranes, notamment de micro -, ultra-, nano-, ou hyperfiltration d'effluents contenant des matières en suspension, notamment de l'eau, en vue de réduire le colmatage des membranes  et d'améliorer la capacité de filtration de celles-ci, caractérisés en ce qu'ils consistent à ajouter à l'effluent, avant son passage sur ladite membrane, une dose d'un réactif de coagulation déstabilisant les matières colloïdales en suspension, qui est de l'ordre de 30 à 80 fois inférieure à l a dose annulant le potentiel Zéta.
Patent CA-2396347-A1 (CA)
Inventor: KHURI-YAKUB PIERRE
IPC: H04R23/00
Filed: 2000-01-04
Abstract: A speaker device for emitting subsonic, sonic or ultrasonic compression waves comprising a generally hollow drum, a rigid emitter plate (108) attached to the drum (100), and a plurality of apertures (112) formed within the plate which are covered by a thin piezoelectric film disposed across the emitter plate (108). A pressure source is coupled to the drum (100) for developing a biasing pressure with respect to the thin film (104) at the apertures (112) to distend the film (104) into an arcuate emitter configuration capable of constricting and extending in response to variations in the applied electrical input at the piezoelectric film (104) to thereby create a compression wave in a surronding environment. Parametric ultrasonic frequency input is supplied to the piezoelectric film (104) to propagate multiple ultrasonic frequencies having a difference component corresponding to the desired subsonic, sonic or ultrasonic frequency range.
Patent CA-2396982-A1 (CA)
Title: Composition for producing biologically degradable shaped bodies and method for producing such a composition
Inventor: KOEBLITZ THOMAS
IPC: C08L101/16
Filed: 2001-01-11
Abstract: The invention relates to a dry mixture, which comprises starch, biologically  degradable fiber material, protein and, optionally, additives, for producing  biologically degradable shaped bodies, and to a method for producing such a dry mixture. The invention additionally relates to a paste that can be baked , whereby this paste comprises starch, biologically degradable fiber material,  protein, water and, optionally, additives. Finally, the invention relates to  shaped bodies that are produced by using said dry mixture or said paste that  is capable of being baked.
Patent CA-2397442-A1 (CA)
Title: Entry control system
Inventor: TEMPLETON ERIC P
IPC: G07C9/00
Filed: 2001-01-11
Abstract: An entry control system (10) includes an access controller (18) generating control signals (20) which garage door opener (12) to either open or close a door (16) permitting access to a controlled area. Access is restricted to the homeowner or other users who are authorized by the homeowner by authentication system (22).
Patent CA-2398199-A1 (CA)
Title: Novel therapeutic agents that use a .beta.3 agonist
Inventor: OGAWA KOHEI
IPC: A61K31/445
Filed: 2001-01-26
Abstract: Remedies containing at least one member selected from the group consisting of cholinolytics, monoamine reuptake inhibitors, lipase inhibitors, selective serotonin reuptake inhibitors, insulin, insulin secretion promoters, biguanide, a-glucosidase inhibitors, insulin resistance improving agents, HMC-CoA reductase inhibitors, anion exchange resins, clofibrate-base drugs and nicotinic acid-base drugs and a compound having a .beta.3-agonistic activity.  The .beta.3 agonist has an activity of inhibiting urination disorder. When used together with a remedy for urination disorder such as propiverine, oxybutynin hydrochloride or tolterodine, it exerts an enhanced anti-urination disorder effect. When used together with an antiobestic agent such as sibutramine or orlistat, it exerts an enhanced antiobestic effect. When used together with an antidiabetic agent such as insulin, glibenclamide, acarbose or rosiglitazone, it exerts an enhanced antidiabetic effect. When used together with an antilipemic drug such as bezafibrate or pravastatin, it exerts an enhanced antilipemic effect.
Patent CA-2399593-A1 (CA)
Title: Antibodies to ccr5
Inventor: RUBEN STEVEN M
IPC: C12N1/21
Filed: 2001-02-09
Abstract: The present invention relates to a novel human protein called human G-protei n Chemokine Receptor (CCR5) HDGNR10, and isolated polynucleotides encoding thi s protein. The invention is also directed to human antibodies that bind Human G- protein Chemokine Receptor (CCR5) HDGNR10 and to polynucleotides encoding those antibodies. Also provided are vectors, host cells, antibodies, and recombinant methods for producing Human G-protein Chemokine Receptor (CCR5) HDGNR10 and human anti-Human G-protein Chemokine Receptor (CCR5) HDGNR10 antibodies. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to this novel human protein and these novel human antibodies.
Patent CA-2401145-A1 (CA)
Inventor: JONGSMA BEREND
IPC: A61P31/12
Filed: 2001-02-15
Abstract: The present invention is directed to processes and compositions for protecting host animals (e.g., chickens) from exposure to virulent infectious bronchitis virus. In ovo administration of live, avirulent strains of IB at appropriate dosage levels on a per egg basis provides an effective and efficient vaccination having acceptable safety and efficacy features.
Patent CA-2403793-A1 (CA)
Inventor: FAVA CARLO
IPC: C10L10/00
Filed: 2001-04-11
Abstract: Cette invention concerne des fuels qui présentent un pouvoir lubrifiant et des propriétés à basse température améliorés ainsi que des additifs destinés à ces carburants.
Patent CA-2404010-A1 (CA)
Inventor: PASSINI REINALDO
IPC: D21C11/00
Filed: 2002-09-17
Abstract: A method for removal of pollutants from a pulping process byproduct liquor, the method comprising injecting an oxygen-containing gas into said liquor and condensin g the water vapor from the stripping gas so as to produce a condensate comprising pollutants. Also a method of controlling the flow rate and/or temperature of a pulping proces s byproduct liquor, the process comprising injecting an oxygen-containing gas into the liquor in a reactor, processing the liquor in a flash tank so as to create a cooled liquor and combining at a least a portion of the cooled liquor with new liquor as the new liquor enters, or while the new liquor is in, the reactor.
Patent CA-2405274-A1 (CA)
Inventor: RUGGIERO ANTHONY J
IPC: H04B10/118
Filed: 2001-04-06
Abstract: Cette invention a trait à un système et à la technique correspondante permettant d'extraire, à distance, une information d'une station de communications par une interrogation effectuée grâce à un faisceau de faible puissance. La conjonction de phase non linéaire du faisceau de faible puissance se traduit par l'existence d'un faisceau de retour codé à haute puissance qui poursuit automatiquement le faisceau en entrée et dont la distorsion atmosphérique est corrigée. On utilise le mélange non dégénéré à quatre ondes intracavitaire dans un laser à grande surface à semi-conducteur dans la station de communications afin de produire le faisceau de retour.
Patent CA-2411167-A1 (CA)
Title: Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
Inventor: EVANS ROBERT K
IPC: C12N15/09
Filed: 2001-06-22
Abstract: Improved polynucleotide vaccine adjuvants and related polynucleotide vaccine formulations are disclosed which are useful in prophylactic or therapeutic vaccine and/or gene therapy-based applications. These adjuvants comprise a block copolymer and a cationic surfactant component. The inclusion of a cationic surfactant results in an increased percentage of polynucleotide that is physically associated with the adjuvant in vitro, resulting in enhanced in vivo immune responses to polynucleotide vaccines.
Patent CA-2411396-A1 (CA)
Title: Inhibiteurs de la hmg coa reductase pour favoriser l'angiogenese
Inventor: WALSH KENNETH
IPC: A61K31/40
Filed: 2001-06-05
Abstract: L'invention concerne des procédés et des compositions pour le traitement d'états associés à une insuffisance vasculaire, ainsi que des méthodes et des compositions pour des dosages permettant la sélection d'agents utiles à cet effet. L'invention porte, notamment, sur des inhibiteurs de la HMG CoA réductase et sur leur utilisation dans la promotion de l'angiogenèse in vivo et dans l'activation d'Akt dans les cellules endothéliales vasculaires, in vitro et in vivo.
Patent CA-2411570-A1 (CA)
Inventor: KISHIMOTO SHOICHI
IPC: G02F1/35
Filed: 2002-11-12
Abstract: An optical wavelength conversion device comprising: a modulating signal generating unit for generating a modulating signal; an optical modulating unit for modulating input light by the modulating signal; and wavelength select means for extracting only a necessary component from an optical signal generated by the optical modulating unit. In the optical wavelength conversion device, the optical modulating unit may be an amplitude modulator or a phase modulator. The modulating signal may be an electrical signal or an optical signal. When the modulating signal is an optical signal, the optical signal consists preferably of light of a plurality of wavelength components.
Patent CA-2412732-A1 (CA)
Inventor: EDER JOSEPH C
IPC: A61B17/12
Filed: 2001-06-20
Abstract: A device (100) for treating an aneurysm including an aneurysm liner (104) expandable to form an inner cavity (135) and a plurality of extender segments (130-1, 130-1) supported in the aneurysm liner (104). The device (100) includes an axial constraint, such as guidewire (100), coupled to the plurality of extender segments (130-1, 130-n) in the liner (104) to axially constrain extender segments (130-1, 130-n) in end to end alignment to bias the liner 104 in a collapsed profile.
Patent CA-2412816-A1 (CA)
Title: Distributed simulation
Inventor: GLOVER STEVEN F
IPC: G06F19/00
Filed: 2001-06-19
Abstract: A method (300) and apparatus (20) are presented to facilitate simulation of complex systems on multiple computing devices. Model authors can specify sta te- related information to be exported for viewing or access by other applicatio ns (33, 34, 36, 38, 39) and models (22, 24, 26, 28). Subsystem models (22, 24, 26, 28) may be written to enable connection with other subsystem models (22,  24, 26, 28) via controlled interfaces (55, 75, 88), such as by defining stat e- related information for export and providing for a particular use of data imported from other models (22, 24, 26, 28) to which a subsystem model (22, 24, 26, 28) is connected. In some embodiments, a consistent distributed simulation API enables cross-platform, multi-device simulation of complex systems, wherein the proprietor of each subsystem simulation can keep its implementation (22, 24, 26, 28) secret but accessible to others.